Perioperative management of patients with liver cancer complicated with sarcopenia  

作　　者：Jiali Xing Xueshuai Wan Xinting Sang Huayu Yang Shunda Du 

机构地区：[1]Department of Liver Surgery,Peking Union Medical College Hospital(PUMCH),Peking Union Medical College(PUMC)&Chinese Academy of Medical Sciences(CAMS),Beijing,China

出　　处：《Hepatobiliary Surgery and Nutrition》2022年第6期906-908,共3页肝胆外科与营养（英文）

基　　金：This work was supported by grants from CAMS Innovation Fund for Medical Sciences(CIFMS)2021-I2M-1-014.

摘　　要：Primary liver cancer is one of the most common digestive system malignancies worldwide,with hepatocellular carcinomas accounting for about 90% of cases.It has a concealed onset,rapid progression,high degree of malignancy,and is difficult to treat,which presents a serious threat to people’s life and health(1).At present,the primary treatment methods for liver cancer include hepatectomy,liver transplantation,transcatheter arterial chemoembolization,systematic treatment,and combined therapy,among which surgical resection is the most important(2,3).

关 键 词：LIVER ARTERIAL TREATMENT 

分 类 号：R73[医药卫生—肿瘤]